Role of Hypoxia in Shaping the Tumor Stroma in Pancreatic Cancer
Role of Hypoxia in Shaping the Tumor Stroma in Pancreatic Cancer
批准号:
10629558
负责人:
Kyoung Eun Lee
金额:
$42.88万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-01 至 2028-04-30
关键词:
3-DimensionalAreaBlood VesselsCCL2 geneCD8-Positive T-LymphocytesCellsClinicalCoculture TechniquesDataDiseaseDisease ProgressionExclusionExtracellular MatrixFibroblastsGoalsHumanHypoxiaHypoxia Inducible FactorImmuneIn VitroInfiltrationInflammatoryKnowledgeLIF geneMacrophageMalignant NeoplasmsMalignant neoplasm of pancreasMediatingMusMyelogenousNeoplasm TransplantationOutcomeOxygenPancreatic Ductal AdenocarcinomaPhenotypeReactionRegulationRoleShapesStressStromal CellsSurvival RateSystemT cell infiltrationT-LymphocyteTarsTestingcancer cellcancer typecopingcytokinedensitydesignexperienceinsightmouse modelneoplastic cellnormoxianovel therapeutic interventionpancreatic cancer cellsrapid growthrecruitresponsetargeted treatmenttherapy resistanttumortumor growthtumor hypoxiatumor progressiontumor-immune system interactions
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest and most aggressive cancer types, and
thus new treatment strategies are urgently needed. Pancreatic cancer cells are surrounded by a dense stroma
consisting of extracellular matrix and noncancerous cells, including fibroblasts and immune cells. Interactions
between tumor cells and the associated stroma are critical for tumor progression and resistance to therapy. Due
to the unusually low vascular density of PDAC, both the tumor and stromal cells experience hypoxia, a condition
of insufficient oxygen availability. To cope with hypoxic stress, both the tumor and stromal compartments
undergo adaptive changes primarily mediated by hypoxia-inducible factor 1ɑ and 2ɑ (HIF1ɑ and HIF2ɑ).
Although PDAC is known to be severely hypoxic and hypoxia predicts poor clinical outcome, the effects of
hypoxia and stromal HIF activation on tumor-stroma interactions in PDAC are not fully understood. Based on
our preliminary observation that inflammatory fibroblasts and macrophages are preferentially located in hypoxic
tumor regions whereas CD8+ T cells are largely excluded from hypoxic regions in PDAC, we hypothesize that
hypoxia drives an immunosuppressive microenvironment by promoting an inflammatory fibroblast phenotype
and in turn modulating infiltration and function of macrophages and CD8+ T cells. In Specific Aim 1, we will
determine how hypoxia and HIFs regulate an inflammatory fibroblast phenotype in PDAC using a three-
dimensional (3D) coculture system of pancreatic tumor cells and fibroblasts and exposing the coculture to either
hypoxia or normoxia, as well as using mouse models lacking fibroblast expression of HIF1ɑ or HIF2ɑ. In Specific
Aim 2, we will define how hypoxia-induced fibroblast-secreted factors and macrophage-intrinsic hypoxic
responses regulate macrophage recruitment and function in PDAC by treating macrophages with conditioned
media derived from 3D tumor cell-fibroblast cocultures under hypoxia, and using mouse models lacking myeloid
expression of HIF1ɑ or HIF2ɑ. In Specific Aim 3, we will determine how macrophages and fibroblasts contribute
to CD8+ T cell exclusion in hypoxic tumor niches by depleting macrophages or blocking a factor secreted from
fibroblasts in syngeneic orthotopic transplanted tumors, injecting a hypoxia probe into mice, and assessing CD8+
T cell infiltration and activation in hypoxic and normoxic tumor regions. Together, the proposed studies will
provide new knowledge on hypoxic regulation of the tumor-stroma crosstalk and inform the optimal design of
stroma-targeting therapeutic strategies for PDAC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: